Actively Recruiting
The STatus Epilepticus Prognosis Study
Led by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Updated on 2024-09-19
50
Participants Needed
1
Research Sites
213 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to improve the prognosis of patients who present with Status Epilepticus (SE). In the first part of this study, the investigators aim to find better markers of good and poor outcomes of SE patients while in the ICU. The objective is to measure the levels of brain protein micro-particles that are detectable in blood samples. The investigators seek to determine whether elevated levels of micro-particles in the bloodstream in SE patients can be used to predict the eventual outcome of survivors. The goal of the second part of the study is to evaluate long-term cognitive outcomes in survivors of SE To date, there is no reliable information to inform what cognitive recovery is like for survivors of SE after ICU discharge. The objective is to use the Creyos cognitive testing platform to assess different domains of cognitive function for up to 1 year after SE onset. Patients who have pre-existing epilepsy but have not had status epilepticus will serve as patient controls for the cognitive testing portion of this study. The third part of this study will evaluate brain changes in survivors of refractory SE. To date, there are no known studies that document to what extent the anatomy of the brain changes following SE. The objective is to characterize these changes by conducting two brain research scans 6 months apart. Patients will be invited to Robart\'s Research Institute for a scan 1-3 months and 6-8 months (6 months apart) after refractory SE to measure structural and functional changes in the brain throughout the recovery process.
CONDITIONS
Official Title
The STatus Epilepticus Prognosis Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years
- Status Epilepticus requiring admission to critical care
- Developed Status Epilepticus while in ICU
- No history of neurologic conditions other than epilepsy that affect cognition (such as dementia, Parkinson's disease, Alzheimer's disease)
- No devastating neurologic injury like cardiac arrest, stroke, or traumatic brain injury
- For non-SE epilepsy controls: diagnosis of epilepsy without history of status epilepticus, no stereotaxic EEG monitoring, English speaking, and no neurologic condition affecting cognition
- For MRI follow-up: diagnosed with refractory status epilepticus in ICU and no MRI contraindications
- For healthy MRI controls: no history of neurologic conditions affecting cognition and no MRI contraindications
You will not qualify if you...
- Not meeting all inclusion criteria
- Acute brain injury or brain tumor causing the status epilepticus
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Lawson Health Research Institute
London, Ontario, Canada, N6C 2R5
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here